Improve Medical Instruments Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 24, 2022 at 04:49 am EDT
Share
Improve Medical Instruments Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 179.56 million compared to CNY 230.57 million a year ago. Revenue was CNY 179.56 million compared to CNY 230.57 million a year ago. Net loss was CNY 37.71 million compared to net income of CNY 33.11 million a year ago. Basic loss per share from continuing operations was CNY 0.12 compared to basic earnings per share from continuing operations of CNY 0.11 a year ago. Diluted loss per share from continuing operations was CNY 0.12 compared to diluted earnings per share from continuing operations of CNY 0.11 a year ago.
Improve Medical Instruments Co Ltd, formerly Guangzhou Improve Medical Instruments Co Ltd, is a China-based company mainly engaged in the production and sales of medical equipment. The Company is also engaged in the financial leasing business of medical equipment. The Company's products include vacuum blood collection systems, liquid biopsy tubes, automatic blood collection tube detachers, thromboelastometers and reagents, hospital intelligent blood collection management systems, sub-medical record systems (EMR) and others. The Company's products also include masks, instruments, reagents and others. The Company's products are exported to Russia, Saudi Arabia, Brazil, South Korea and other countries and regions.